EVOCOR 2.5 MG BOX OF 30

Treatment of stable, moderate to severe chronic heart failure with reduced systolic ventricular function (ejection fraction ≤ 35%, as determined by echocardiography), as an adjunct to angiotensin-converting enzyme (ACE) inhibitors and diuretics, and optionally digitalis.

Category: Tag:

Description

Specialty EVOCOR
Dosage 2.5 mg
Form Film-coated tablet
Presentation B/30
Primary Packaging Blister
Specification ALU, PVC, PVDC
INN BISOPROLOL
VEIC Classification Essential
Therapeutic Class CARDIOVASCULAR SYSTEM
Subclass BETA-BLOCKING AGENTS
Laboratory PHILADELPHIA PHARMA
Schedule A
Shelf Life 24 (months)
Generic/Brand Generic
Marketing Authorization 9353173
Marketing Authorization Date 2017-01-25
Range Cardio Metabolic

Reviews

There are no reviews yet.

Be the first to review “EVOCOR 2.5 MG BOX OF 30”